HEALTH

Pharmaca stores collecting unused OTCs, supplements and more for disposal

BY Jenna Duncan

BOULDER, Colo. Pharmaca Integrative Pharmacy has launched a pharmaceutical drop-off program at each of its 22 pharmacy locations.

Pharmacy customers may drop off their expired or unneeded prescription medications, expired vitamins and supplements, OTCs, needles and syringes and medication samples with the exception of controlled substances to the collection site, and Pharmaca will send all items to be destroyed, the company said in a release.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Flavours launches NutraBitz all-natural, probiotic soft chews

BY Michael Johnsen

CORONA, Calif. Flavours Inc. on Monday announced the introduction of NutraBitz, a line of all-natural, oat-based soft chews containing both prebiotics and probiotics for private label applications.

“Probiotics are one of the hottest market trends today, but right now consumers can’t get them in delivery forms that make taking probiotics enjoyable. NutraBitz changes that,” Flavours Inc. director of sales, Tara Foster, said.

Flavours plans to showcase the new product offering Supply Side West, which is being held Oct. 22-24 in Las Vegas.

According to the company, the idea for NutraBitz was inspired by the continuing emergence of medical research demonstrating the benefits of probiotics in a wide variety of health conditions and growing consumer interest and demand for probiotic alternatives to refrigerated yogurts and probiotic capsules and tablets. “Consumers are now much more aware of the benefits of probiotics and are looking for other ways of getting them into the daily diet,” the company stated.

Each 5.5 gram NutraBitz soft chew is 15-20 calories and contains 1 billion CFU of the GanedenBC30 strain of Bacillus coagulans probiotics. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

GlaxoSmithKline and Merix settle extended dispute over advertising practices

BY Michael Johnsen

CHICAGO According to court documents filed last month, Merix Pharmaceutical and GlaxoSmithKline have settled a three-year dispute over advertising and competition practices for an undisclosed amount. “In exchange for certain consideration, the settlement agreement calls for Merix to dismiss with prejudice its claims against GSK, with each side to bear its own costs, expenses and attorneys’ fees,” the court documents, filed Sept. 2, read.

Merix had filed suit in March 2005 charging that certain advertising claims made by GlaxoSmithKline in support of its cold sore remedies Abreva and Valtrex may be false and misleading, using unreliable test data to promulgate advertising claims in an intentional effort to deceive doctors and the public.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?